[go: up one dir, main page]

ZA200904323B - DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders - Google Patents

DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders

Info

Publication number
ZA200904323B
ZA200904323B ZA200904323A ZA200904323A ZA200904323B ZA 200904323 B ZA200904323 B ZA 200904323B ZA 200904323 A ZA200904323 A ZA 200904323A ZA 200904323 A ZA200904323 A ZA 200904323A ZA 200904323 B ZA200904323 B ZA 200904323B
Authority
ZA
South Africa
Prior art keywords
app
binding
neurological disorders
treating neurological
antibodies inhibiting
Prior art date
Application number
ZA200904323A
Inventor
Anatoly Nikolaev
Marc Tessier-Lavigne
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200904323B publication Critical patent/ZA200904323B/en

Links

ZA200904323A 2006-12-22 2007-12-21 DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders ZA200904323B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87152806P 2006-12-22 2006-12-22

Publications (1)

Publication Number Publication Date
ZA200904323B true ZA200904323B (en) 2010-08-25

Family

ID=41495884

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904323A ZA200904323B (en) 2006-12-22 2007-12-21 DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders

Country Status (2)

Country Link
CN (1) CN101616934A (en)
ZA (1) ZA200904323B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN06588A (en) * 2010-02-10 2015-10-23 Novartis Ag
WO2012093732A1 (en) * 2011-01-07 2012-07-12 セイコーエプソン株式会社 Antibody to signal peptide of amyloid precursor protein
WO2016149398A1 (en) * 2015-03-16 2016-09-22 Regeneron Pharmaceuticals, Inc. Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
KR20200112745A (en) * 2019-03-20 2020-10-05 주식회사 굳티셀 Composition for preventing or treating brain and nervous system disease

Also Published As

Publication number Publication date
CN101616934A (en) 2009-12-30

Similar Documents

Publication Publication Date Title
ZA201004219B (en) Dr6 antibodies inhibiting the binding of dr6 to app,and uses thereof in treating neurological disorders
EP2170309A4 (en) Methods and compositions for treating disorders
GB201001047D0 (en) Methods and compositions for the treatment of neurological disorders
WO2009052431A3 (en) Cd19 binding agents and uses thereof
LT2374472T (en) Compositions and methods for treating ophthalmic disorders
EP2152266A4 (en) Compositions and methods for treating disorders associated with salt or fluid retention
ZA200610661B (en) Compositions and methods for treating neurological disorders
ZA201001789B (en) Composition and methods for use for antibodies against sclerostin
IL205279A0 (en) Methods of treating urogenital - neurological disorders using modified clostridial toxins
EP2041180A4 (en) Ilt3 binding molecules and uses therefor
EP2083857A4 (en) Methods for treating mica-related disorders
IL208518A0 (en) Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
GB2466912B (en) Compositions and methods for treating lysosomal disorders
EP2331088A4 (en) Compositions and methods for treating psychiatric disorders
GB0621973D0 (en) Binding molecules and uses thereof
IL202424A (en) Telomerase activating compounds for use in treating diseases, disorders and conditions related thereto
EP2200611A4 (en) Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
EP1859277A4 (en) Treating neurological disorders
IL205730A0 (en) Methods for treating obesity and obesity related diseases and disorders
GB201010044D0 (en) Methods for treating social disorders
EP2205255A4 (en) Herbal compositions and methods for treating hepatitic disorders
IL205578A0 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
IL184578A0 (en) Method and composition for treating central nervous system disorders
IL193697A0 (en) Methods for treating cognitive and other disorders
IL196561A0 (en) Compositions and methods for treating diabetes and neuropsychological dysfunction